# Quantum Biopharma Ltd.: Form 6-K, filed Mar 30, 2026

- Company: [Quantum Biopharma Ltd.](/companies/qntm.md) (CIK 1771885)
- Form: 6-K
- Filed: 2026-03-30
- Accepted by EDGAR: Mar 30, 2026, 07:50 ET
- Period: 2026-03-30
- Accession: 0001171843-26-002008
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1771885/000117184326002008/f6k_033026.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1771885/000117184326002008/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1771885/000117184326002008/f6k_033026.htm

Filed Mar 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-002008. Last ingested by Listed: Nov 5, 2026, 19:55 ET. No prices; not investment advice.